Named as a key player in 99 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Biosimilars | Pharmaceuticals | $36.9 Bn | 24.9% |
| Contraceptives Drugs | Pharmaceuticals | $25.2 Bn | 6.8% |
| Antipyretics OTC | OTC & Nutraceuticals | – | – |
Named as key players in the same markets as Viatris (number of shared markets).
Johnson & Johnson2 shared markets
Pfizer Inc.2 shared markets
AbbVie Inc.1 shared market
Afaxys, Inc.1 shared market
Agile Therapeutics1 shared market
Amgen Inc.1 shared market
BASF SE1 shared market
Bayer AG1 shared market